Growth stage companies want working capital to develop products as well as fund the day-to-day operations without diluting shareholder equity. Debt capital financing has historically been the way businesses have funded working capital gaps with term loans, revolving lines of credit, recurring revenue loans, equipment and asset-backed loans, or a mixture thereof. Today’s economic landscape is rich with choices and a multifaceted approach is necessary to achieve the best structure and lowest cost of capital.
We Understand How to Structure Debt Capital
At Armentum, we work with clients to optimize preferences, including cost of capital, structure of debt, and debt syndication. Key use of proceeds include growth capital, debt refinancing, dividend recapitalization, and acquisition financings, or a combination thereof, while some of the more common transaction structures we advise on include senior, mezzanine and subordinated debt, unitranche structures, accordion and revolving facilities, and royalty and revenue interest structures.
We Raise Debt between $10MM and $200MM.
Debt Capital Raising Solutions
Let’s discuss how Armentum can facilitate debt capital financing for your company.
JDS TherapeuticsSenior Debt $25,000,000
G1 TherapeuticsSenior Debt $150,000,000
ClearsenseSenior Debt $25,000,000
Mersana TherapeuticsSenior Debt $100,000,000
ViscogliosiNAV-based financing $70,000,000
Pi-CardiaSenior Debt $21,000,000
GetaroundSenior Debt $75,000,000
Eloxx PharmaceuticalsSenior Debt $30,000,000
Armentum Partners is an independent financial services firm focused on facilitating debt transactions primarily for technology and healthcare companies. We provide non-dilutive capital-raising solutions, including asset-backed lending, venture debt, middle market debt, and royalty financing solutions. Our deep industry knowledge, years of experience, and long-term, trusted relationships with lenders allow us to help our clients optimize their capital structure and facilitate growth.